The current status of intermittent androgen deprivation (IAD) therapy for prostate cancer: putting IAD under the spotlight.

@article{Tunn2007TheCS,
  title={The current status of intermittent androgen deprivation (IAD) therapy for prostate cancer: putting IAD under the spotlight.},
  author={Ulf W. Tunn},
  journal={BJU international},
  year={2007},
  volume={99 Suppl 1},
  pages={19-22; discussion 23-4}
}
Intermittent androgen deprivation (IAD) is one approach to hormonal therapy for prostate cancer that has been developed with the aim of minimizing the negative effects of therapy while maximizing the clinical benefits and the patient's quality of life (QoL). It can be used in any clinical situation where continuous AD (CAD) treatment could be applied. IAD… CONTINUE READING